We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.19%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.14%
2 Energy 13.42%
3 Healthcare 10.78%
4 Financials 9.95%
5 Technology 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NIO
551
DELISTED
NUVEEN MUNICIPAL OPPORTUNITY FUND INC
NIO
$1.03M 0.03%
78,117
+302
+0.4% +$3.88K
CLF icon
552
Cleveland-Cliffs
CLF
$6.93B
$1.03M 0.03%
39,320
-15,654
-28% -$386K
IMKTA icon
553
Ingles Markets
IMKTA
$1.57B
$1.03M 0.03%
38,035
+5
+0% +$131
XME icon
554
State Street SPDR S&P Metals & Mining ETF
XME
$4.45B
$1.03M 0.03%
24,457
+3,361
+16% +$132K
RTN
555
DELISTED
Raytheon Company
RTN
$1.02M 0.03%
11,277
+2,753
+32% +$230K
HIMX
556
Himax Technologies
HIMX
$2.28B
$1.02M 0.03%
69,489
+37,195
+115% +$394K
CAG icon
557
Conagra Brands
CAG
$7.29B
$1.02M 0.03%
38,849
-67,680
-64% -$1.69M
RF icon
558
Regions Financial
RF
$24.3B
$1.02M 0.03%
102,650
-4,942
-5% -$47.6K
BSX icon
559
Boston Scientific
BSX
$63.6B
$1.01M 0.03%
84,029
+194
+0.2% +$2.29K
CTR
560
DELISTED
ClearBridge MLP and Midstream Total Return Fund Inc.
CTR
$1.01M 0.03%
9,160
+430
+5% +$47.2K
WFM
561
DELISTED
Whole Foods Market Inc
WFM
$1.01M 0.03%
17,422
+17
+0.1% +$1.01K
FPX icon
562
First Trust US Equity Opportunities ETF
FPX
$1.43B
$1.01M 0.03%
22,180
+4,690
+27% +$201K
RSP icon
563
Invesco S&P 500 Equal Weight ETF
RSP
$97.5B
$1M 0.03%
14,116
+1,383
+11% +$94.5K
BCPC
564
Balchem Corp
BCPC
$5.34B
$1M 0.03%
17,125
-350
-2% -$19.8K
CCI.PRA
565
DELISTED
Crown Castle International Corp.
CCI.PRA
$1M 0.03%
+10,000
New +$1.01M
VTRS icon
566
Viatris
VTRS
$19.5B
$1M 0.03%
23,110
+84
+0.4% +$3.45K
CRH icon
567
CRH
CRH
$57.7B
$1M 0.03%
39,215
+1,500
+4% +$37.1K
SLX icon
568
VanEck Steel ETF
SLX
$167M
$997K 0.03%
20,053
+53
+0.3% +$2.54K
VCI
569
DELISTED
VALASSIS COMMUNICATIONS INC
VCI
$993K 0.03%
+28,984
New +$857K
DAKT icon
570
Daktronics
DAKT
$845M
$982K 0.03%
62,603
+2,160
+4% +$28.7K
AWK icon
571
American Water Works
AWK
$27.4B
$979K 0.03%
23,173
-2,307
-9% -$96.7K
JCI icon
572
Johnson Controls International
JCI
$85.1B
$976K 0.03%
18,176
+2,990
+20% +$147K
HHH icon
573
Howard Hughes
HHH
$3.71B
$966K 0.03%
8,439
+456
+6% +$49.5K
PMFG
574
DELISTED
PMFG INC COM STK (DE)
PMFG
$965K 0.03%
+106,650
New +$832K
HMA
575
DELISTED
HEALTH MGMT ASSOC INC CL-A
HMA
$960K 0.03%
73,318
+11,185
+18% +$145K

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.